摘要
目的观察咳嗽变异性哮喘患者接受沙美特罗替卡松治疗的临床效果。方法随机选取2014年1月—2015年7月期间该院收治的50例咳嗽变异性哮喘患者作为受试对象,根据不同治疗方法将所有病例分为观察组和对照组,两组各25例患者。对照组给予孟鲁司特钠治疗,观察组则应用沙美特罗替卡松治疗。比较两组治疗效果。结果观察组患者夜间咳嗽缓解时间为(2.9±0.9)h、胸闷气短缓解时间(5.2±2.8)h,均短于对照组,两组相比差异均有统计学意义(P<0.05)。结论沙美特罗替卡松能快速改善咳嗽变异型哮喘患者症状,值得推广应用于临床。
Objective To observe the clinical effect of seretide in treatment of 25 cases with cough variant asthma. Methods 50 cases of patients with cough variant asthma admitted and treated in our hospital from January 2014 to July 2015 were selected as the test subject and divided into two groups with 25 cases in each, the control group were treated with montelukast, the observation group were treated with seretide, the treatment effect of the two groups was compared. Results The nocturnal cough relief time and dyspnea chest discomfort relief time were respectively(2.9±0.9)h and(5.2±2.8)h in the observation group, which were shorter than those in the control group, the differences had statistical significance between the two groups by comparison,(P0.05). Conclusion Seretide can quickly improve the symptoms in patients with cough variant asthma, and it is worth promotion and application in clinic.
出处
《中外医疗》
2016年第6期125-126,共2页
China & Foreign Medical Treatment